New Kaiyuan: Announcement on Obtaining a Commitment Letter for Special Loans for Stock Repurchases from Financial Institutions
Securities code: 300109 Securities abbreviation: New Kaiyuan Announcement number: 2026-049
Boai New Kaiyuan Medical Technology Group Co., Ltd.
Announcement on Obtaining a Commitment Letter for Special Loans for Stock Repurchases from Financial Institutions
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Boai New Kaiyuan Medical Technology Group Co., Ltd. (hereinafter referred to as the "Company") held the 23rd meeting of the fifth board of directors on April 22, 2026 to review and approve the "Proposal on the Plan to Repurchase the Company's Shares through Centralized Bidding Transactions". The company's source of funds for repurchasing shares is its own funds or special repurchase loans. The shares repurchased this time will be used for equity incentive plans and/or employee stock ownership plans. The total amount of funds required to repurchase shares shall not be less than RMB 250 million (including the principal amount) and shall not exceed RMB 300 million (including the principal amount). The specific amount shall be based on the total amount of funds actually used when the repurchase period expires. The upper limit of the repurchase price is 27.23 yuan/share; the period for repurchasing shares is within 12 months from the date the company's board of directors considers and approves the repurchase plan. For details, please refer to the "Repurchase Report" (announcement number: 2026-044) disclosed by the company on April 27, 2026 on cninfo.com (www.cninfo.com.cn).
1. Obtaining a special loan commitment letter for stock repurchase from a financial institution
The company applied for a special loan for stock repurchase from China CITIC Bank Co., Ltd. Jiaozuo Branch in accordance with the "Notice of the People's Bank of China, the State Administration of Financial Supervision, and the China Securities Regulatory Commission on Matters Concerning the Establishment of Stock Repurchases, Increases and Re-Loans" and subsequent policy updates.
Today, the company obtained the "Loan Commitment Letter" issued by China CITIC Bank Co., Ltd. Jiaozuo Branch (hereinafter referred to as "CITIC Bank Jiaozuo Branch"), promising to provide special loan support for the company's share repurchase. The main contents are as follows:
Loan bank: China CITIC Bank Co., Ltd. Jiaozuo Branch.
Committed loan amount: the maximum amount shall not exceed RMB 270,000,000.
Loan term: 3 years.
Purpose of loan: repurchase issued and listed stocks.
The loan commitment letter shall take effect from the date when the person in charge of China CITIC Bank Jiaozuo Branch or the authorized agent signs or stamps the name seal and the official seal of China CITIC Bank Jiaozuo Branch (i.e. the date of issuance), and will be valid until May 13, 2027.
2. Other instructions
The loan commitment letter obtained this time can provide financing support for the company's share repurchase. The specific loan matters shall be subject to the credit agreement/loan contract signed between the company and the lending bank. Obtaining a special loan commitment letter for stock repurchase from a financial institution does not represent the company's commitment to the amount of this repurchase. The specific repurchase amount shall be based on the funds actually used at the end of this repurchase.
The company will subsequently choose an opportunity to implement this repurchase plan within the repurchase period based on market conditions, and will perform its information disclosure obligations in a timely manner in accordance with relevant laws and regulations. Investors are kindly requested to pay attention to investment risks.
3. Documents for reference
- "Loan Commitment Letter".
Announcement hereby
Boai New Kaiyuan Medical Technology Group Co., Ltd. Board of Directors
May 15, 2026